|Articles|February 21, 2017
FDA Awards ICON with Project Validating PROs
ICON plc announced that the US FDA has awarded the company with a project validating three Patient Reported Outcomes instruments that will measure clinical endpoints in antibacterial drug trials.
Advertisement
ICON plc announced that the US FDA has awarded the company with a project validating three Patient Reported Outcomes instruments that will measure clinical endpoints in antibacterial drug trials.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
2
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
3
FDA Approves Caplyta as Adjunctive Therapy for Major Depressive Disorder Based on Positive Phase III Results
4
Using AI and Tokenized Data to Match Patients to Protocols
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
